The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics.
An effective treatment for metastatic melanoma remains one of the most elusive goals in all of oncology. Several generations of therapeutic trials have yet to yield any agents that can significantly prolong survival for widespread disease. Despite this disheartening history, our understanding of the biology and molecular genetics of melanoma hold the promise of a new era of molecular targets. One pathway that appears to be universally activated in and critically needed for melanoma growth is the Ras/mitogen activated protein (MAP) kinase signaling cascade. Since the enzymatic functions of the signaling partners are well characterized, this pathway offers many potential "druggable" candidates including Braf, Mek and Ras itself. In this review, we describe this pathway in the context of melanoma tumorigenesis and discuss some of the current relevant pharmacologic treatments and clinical trials.
Jarell
Abel D
AD
Department of Dermatology;
Lawrence
Donald
D
Tsao
Hensin
H
J Invest Dermatol. 2004 Feb;122(2):337-41
15009714
Int J Cancer. 2006 Nov 15;119(10):2261-71
16894562
Int J Cancer. 2003 Jun 10;105(2):165-75
12673674
Curr Med Chem. 2007;14(7):735-43
17346159
Curr Treat Options Oncol. 2006 Nov;7(6):427-37
17032555
J Clin Oncol. 2006 Mar 20;24(9):1363-9
16446323
Arch Dermatol. 2006 Nov;142(11):1510-1
17116852
Cell Regul. 1991 May;2(5):357-71
1654126
Chem Biol. 1999 Aug;6(8):559-68
10421767
Cell. 2004 Mar 19;116(6):855-67
15035987
J Med Chem. 2006 Jan 12;49(1):407-16
16392826
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Nature. 2006 Jan 19;439(7074):358-62
16273091
Cell Biol Int. 2007 Jul;31(7):748-51
17337216
Immunol Allergy Clin North Am. 2006 Aug;26(3):575-92
16931294
Hum Mutat. 2007 Jun;28(6):578-88
17295241
Annu Rev Genet. 2004;38:365-411
15568981
N Engl J Med. 2004 Sep 2;351(10):998-1012
15342808
Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2376s-2383s
16609062
Arch Dermatol. 1994 Mar;130(3):355-8
8129415
Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2301s-2307s
16609049
Cold Spring Harb Symp Quant Biol. 2005;70:461-7
16869784
Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2366s-2370s
16609060
Bioorg Med Chem Lett. 2000 Feb 7;10(3):223-6
10698440
CA Cancer J Clin. 2007 Jan-Feb;57(1):30-42
17237034
Bioorg Med Chem Lett. 2004 Feb 9;14(3):783-6
14741289
Br J Cancer. 2006 Sep 4;95(5):581-6
16880785
J Clin Oncol. 2006 Sep 10;24(26):4340-6
16908931
Curr Opin Oncol. 2006 Nov;18(6):615-21
16988583
J Am Acad Dermatol. 2007 Mar;56(3):527-8
17241689
Cancer Res. 2003 Feb 15;63(4):756-9
12591721
Cancer Cell. 2002 Feb;1(1):31-6
12086885
Oncogene. 2003 May 19;22(20):3063-9
12789281
Clin Cancer Res. 2006 Mar 15;12(6):1785-93
16551863
Cancer. 2006 May 1;106(9):2005-11
16565971
Oncogene. 2004 Aug 19;23(37):6292-8
15208680
J Natl Cancer Inst. 2006 Mar 1;98(5):326-34
16507829
Clin Cancer Res. 2002 Dec;8(12):3728-33
12473582
Nature. 2002 Jun 27;417(6892):949-54
12068308
Science. 1997 Dec 5;278(5344):1812-5
9388187
Curr Opin Genet Dev. 2007 Feb;17(1):3-7
17208434
Expert Rev Anticancer Ther. 2006 Mar;6(3):313-9
16503848
Drugs Today (Barc). 2005 Dec;41(12):773-84
16474853
J Clin Oncol. 2005 Aug 10;23(23):5281-93
16009947
Lancet Oncol. 2001 Jan;2(1):18-26
11905614
Am J Dermatopathol. 2003 Oct;25(5):365-70
14501284
Expert Opin Investig Drugs. 2006 Jun;15(6):709-19
16732721
Cancer Res. 2007 Jan 1;67(1):122-9
17210691
Genes Chromosomes Cancer. 1990 Mar;1(4):257-69
2278957
J Clin Oncol. 2006 Jun 1;24(16):2505-12
16636341
Cancer Res. 2003 Sep 1;63(17):5198-202
14500344
Cell. 1991 May 17;65(4):663-75
2032290
Curr Pharm Des. 2002;8(25):2255-7
12369853
Oncogene. 2007 Jul 5;26(31):4563-70
17297468
Br J Cancer. 2005 Apr 25;92(8):1398-405
15846297
Nature. 2005 Jul 7;436(7047):117-22
16001072
Proc Natl Acad Sci U S A. 1982 Jun;79(11):3637-40
6285355
J Clin Oncol. 2005 Sep 20;23(27):6771-90
16170185
N Engl J Med. 2007 Jan 11;356(2):125-34
17215530
Bioorg Med Chem Lett. 2006 Jan 15;16(2):378-81
16260133
Cold Spring Harb Symp Quant Biol. 2005;70:25-34
16869735
Nature. 2007 Feb 22;445(7130):851-7
17314971
Cancer Res. 2006 Feb 1;66(3):1611-9
16452220
Cancer Res. 2004 Oct 1;64(19):7099-109
15466206
Cancer Res. 2002 Dec 1;62(23):6997-7000
12460918